These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 2952821

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?
    Brouwer RM, Wenting GJ, Visser W, Schalekamp MA.
    Vasa Suppl; 1987; 18():64-7. PubMed ID: 3299817
    [No Abstract] [Full Text] [Related]

  • 23. The response of skin perfusion and of rheological and immunological variables to intravenous prostanoid administration in Raynaud's phenomenon secondary to collagenosis.
    Drinda S, Neumann T, Pöhlmann G, Vogelsang H, Stein G, Wolf G, Hein G.
    Vasa; 2005 Nov; 34(4):243-9. PubMed ID: 16363279
    [Abstract] [Full Text] [Related]

  • 24. The relationship between subjective vasospastic complaints and finger blood flow measurements in Raynaud's phenomenon.
    Leesmans E, Bartelink ML, Wollersheim H, Thien T.
    Neth J Med; 1993 Aug; 43(1-2):13-7. PubMed ID: 8232689
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Skin blood flow in patients with systemic sclerosis and Raynaud's phenomenon: effects of oral L-arginine supplementation.
    Khan F, Belch JJ.
    J Rheumatol; 1999 Nov; 26(11):2389-94. PubMed ID: 10555898
    [Abstract] [Full Text] [Related]

  • 27. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Nov; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome.
    Lau CS, Khan F, McLaren M, Bancroft A, Walker M, Belch JJ.
    Rheumatol Int; 1991 Nov; 11(4-5):163-8. PubMed ID: 1838424
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Blood rheology in Raynaud's disease].
    Larcan A, Schmidt C, Stoltz JF, Voisin P.
    J Mal Vasc; 1984 Nov; 9(1):1-6. PubMed ID: 6707529
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effects of topically applied hexyl nicotinate lotion on the cutaneous blood flow in patients with Raynaud's phenomenon.
    Bunker CB, Lanigan S, Rustin MH, Dowd PM.
    Br J Dermatol; 1988 Dec; 119(6):771-6. PubMed ID: 3203071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.